Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report fkansteiner Thu, […]
Month: February 2022
Seagen, Genmab run ‘CeMe’ cervical cancer campaign amid Tivdak launch badams Thu, 02/10/2022 – 06:38
AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec badams Thu, […]
I know it’s not covidI’ve become so familiar with the line “I know it’s not covid because my […]
The UK’s Competition and Markets Authority (CMA) has fined several drug companies more than £35m in total for […]
Current models of maternity care in the UK are failing to reach pregnant women living in adverse social […]
We were delighted to see obstructive sleep apnoea (OSA) flagged as a common risk factor for development of […]
The gaping injustices and inequalities that covid-19 has exposed globally have prompted us to try to ensure that […]
Research demonstrates that people who live with peanut allergies face isolation and discrimination
Diurnal’s pioneering phase 2 study evaluates modified-release hydrocortisone for adrenal insufficiency